Clinical Trials Logo

Clinical Trial Summary

If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02257983
Study type Interventional
Source Edison Pharmaceuticals Inc
Contact
Status Completed
Phase Phase 2
Start date October 31, 2014
Completion date February 29, 2016

See also
  Status Clinical Trial Phase
Terminated NCT01345474 - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL) Phase 3
Terminated NCT02903355 - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL) Phase 3
Withdrawn NCT02049073 - Prevention of Noise-induced Hearing Loss Phase 1/Phase 2
Completed NCT02259595 - Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC Phase 1
Completed NCT00808470 - Micronutrients to Prevent Noise-induced Hearing Loss Phase 2
Recruiting NCT01727492 - Prevention of Noise-induced Damage by Use of Antioxidants N/A
Completed NCT01454895 - Test of a Web-based Intervention to Promote Hearing Protector Use N/A
Completed NCT02472821 - Test of Hearing Health Education Programs for Farm and Rural Youth N/A